|Articles|November 7, 2016

CS Medical Announces FDA Clearance of Single-Use, High-Level Disinfectant Chemistry

CS Medical announces FDA 510(k) clearance of a new single-use, high-level disinfectant chemistry for the TD 100® Automated TEE Ultrasound Probe Disinfector. The FDA cleared high-level disinfectant TD-8® is OPA based and delivers a 5-minute high-level disinfection for TEE probes. The disinfectant will operate in the TD 100® identically to TD-5®, which was previously the only FDA cleared high-level disinfectant for the TD 100®.

CS Medical’s president, Mark Leath, stated, “I am pleased and excited to bring this additional high-level disinfectant solution to the healthcare market. We, at CS Medical, hope this product will continue to exceed both current and future customer expectations. I am extremely proud of our technical team for the development and delivery of this new high-level disinfectant chemistry.”

For more than 10 years, CS Medical has provided the TD 100® Automated TEE Ultrasound Probe Disinfector to healthcare facilities throughout the United States. To date, the TD 100® has completed over 2.3 million successful disinfections with TD-5® and continues to provide validated and repeatable high-level disinfection for “dirty” TEE probes.

CS Medical is focused on all aspects of TEE ultrasound probe care with products like TEEZyme™ enzymatic sponges, QwikDry™ TEE drying cloths, electrical leakage testing, and HEPA filtered ultrasound probe storage.

Source: CS Medical LLC


Related to this article

Water  (Adobe Stock 456102510 by stockphoto-graf)
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERIS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
AORN26 New Orleans 2026  (Adobe Stock)
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.